Retour

Choisissez votre région

Corporate

Europe:

Drapeau Albanie Albanie Drapeau Bosnie-Herzégovine Bosnie-Herzégovine Drapeau Bulgarie Bulgarie Drapeau Croatie Croatie Drapeau Chypre Chypre Drapeau Monténégro Monténégro Drapeau République Tchèque République Tchèque Drapeau Danemark Danemark Drapeau Estonie Estonie Drapeau Espagne Espagne Drapeau Kosovo Kosovo Drapeau Lituanie Lituanie Drapeau Lettonie Lettonie Drapeau Luxembourg Luxembourg Drapeau Macédoine Macédoine Drapeau Allemagne Allemagne Drapeau Pologne Pologne Drapeau Portugal Portugal Drapeau Roumanie Roumanie Drapeau Serbie Serbie Drapeau Slovaquie Slovaquie Drapeau Slovénie Slovénie Drapeau Suisse Suisse Drapeau Suède Suède Drapeau Turquie Turquie Drapeau Ukraine Ukraine Drapeau Hongrie Hongrie Drapeau Royaume-Uni Royaume-Uni Drapeau Italie Italie

Asie:

Drapeau Émirats Arabes Unis Émirats Arabes Unis Drapeau Hong Kong Hong Kong Drapeau Koweït Koweït Drapeau Liban Liban

Afrique:

Drapeau Afrique du Sud Afrique du Sud

Demandez un entretien de conseil sur les cellules souches

En savoir plus

Contactez-nous dès aujourd'hui !

Vous souhaitez en savoir plus sur nos services ? Remplissez le formulaire ci-dessous et nous vous contacterons dans les plus brefs délais afin de vous fournir toutes les informations nécessaires et de répondre à vos questions.

    +41
    • United Kingdom+44
    • Albania (Shqipëri)+355
    • Andorra+376
    • Armenia (Հայաստան)+374
    • Austria (Österreich)+43
    • Azerbaijan (Azərbaycan)+994
    • Belarus (Беларусь)+375
    • Belgium (België)+32
    • Bosnia and Herzegovina (Босна и Херцеговина)+387
    • Bulgaria (България)+359
    • Croatia (Hrvatska)+385
    • Cyprus (Κύπρος)+357
    • Czech Republic (Česká republika)+420
    • Denmark (Danmark)+45
    • Estonia (Eesti)+372
    • Finland (Suomi)+358
    • France+33
    • Georgia (საქართველო)+995
    • Germany (Deutschland)+49
    • Greece (Ελλάδα)+30
    • Hungary (Magyarország)+36
    • Iceland (Ísland)+354
    • Ireland+353
    • Italy (Italia)+39
    • Kazakhstan (Казахстан)+7
    • Latvia (Latvija)+371
    • Liechtenstein+423
    • Lithuania (Lietuva)+370
    • Luxembourg+352
    • Macedonia (FYROM) (Македонија)+389
    • Malta+356
    • Moldova (Republica Moldova)+373
    • Monaco+377
    • Montenegro (Crna Gora)+382
    • Netherlands (Nederland)+31
    • Norway (Norge)+47
    • Poland (Polska)+48
    • Portugal+351
    • Romania (România)+40
    • Russia (Россия)+7
    • San Marino+378
    • Serbia (Србија)+381
    • Slovakia (Slovensko)+421
    • Slovenia (Slovenija)+386
    • Spain (España)+34
    • Sweden (Sverige)+46
    • Switzerland (Schweiz)+41
    • Turkey (Türkiye)+90
    • Ukraine (Україна)+380
    • United Kingdom+44
    • Vatican City (Città del Vaticano)+39

    Nous tenons à vous informer que les données personnelles fournies dans le formulaire seront traitées par FamiCord Suisse, dont le siège est en Suisse (BusinessPark Zug Sumpfstrasse 26, 6302 Zug), afin de vous contacter par téléphone dans le cadre de la fourniture d'informations de service.

    Image

    Liste des patients
    traités

    Liste des utilisations des cellules souches approuvées par les laboratoires du groupe Famicord:

    Image
    Lp.
    Source
    Type de source
    Diagnostic
    Domaine médical
    Année d'application
    Thérapie
    Pays
    Âge du bénéficiaire
    Tout
    Tout
    Tout
    Tout
    Tout
    Tout
    Tout
    Tout
    1
    Cord Tissue
    Allogeneic - Related
    Chronic renal disease
    Endocrinology
    2025
    Experimental Therapy
    Romania
    50
    2
    Cord Tissue
    Allogeneic - Related
    Autism
    Neurology
    2025
    Experimental Therapy
    Romania
    6
    3
    Cord Tissue
    Autologous
    Autism
    Neurology
    2025
    Experimental Therapy
    Romania
    6
    4
    Cord Tissue
    Allogeneic - Unrelated
    Degenerative and traumatic cartilage damage
    Orthopedy
    2025
    Experimental Therapy
    Poland
    57
    5
    Cord Tissue
    Allogeneic - Unrelated
    Cerebral Palsy
    Neurology
    2025
    Experimental Therapy
    Poland
    3
    6
    Cord Tissue
    Allogeneic - Unrelated
    Cerebral Palsy
    Neurology
    2025
    Experimental Therapy
    Poland
    3
    7
    Cord Tissue
    Allogeneic - Unrelated
    Cerebral Palsy
    Neurology
    2025
    Experimental Therapy
    Poland
    2
    8
    Cord Tissue
    Allogeneic - Unrelated
    Autism
    Neurology
    2025
    Experimental Therapy
    Poland
    5
    9
    Cord Tissue
    Allogeneic - Unrelated
    Cerebral Palsy
    Neurology
    2025
    Experimental Therapy
    Poland
    11
    10
    Cord Tissue
    Allogeneic - Unrelated
    Degenerative and traumatic cartilage damage
    Orthopedics
    2025
    Experimental Therapy
    Poland
    54
    11
    Cord Tissue
    Allogeneic - Unrelated
    Degenerative and traumatic cartilage damage
    Orthopedics
    2025
    Experimental Therapy
    Poland
    78
    12
    Cord Tissue
    Allogeneic - Unrelated
    Autism
    Neurology
    2025
    Experimental Therapy
    Poland
    6
    13
    Cord Tissue
    Allogeneic - Unrelated
    Degenerative and traumatic cartilage damage
    Orthopedics
    2025
    Experimental Therapy
    Poland
    58
    14
    Cord Tissue
    Autologous
    Autism
    Neurology
    2025
    Experimental Therapy
    Romania
    5
    15
    Cord Tissue
    Allogeneic - Related
    Autism
    Neurology
    2025
    Experimental Therapy
    Romania
    5
    16
    Cord Tissue
    Allogeneic - Unrelated
    Autism
    Neurology
    2025
    Experimental Therapy
    Poland
    4
    17
    Cord Tissue
    Allogeneic - Unrelated
    Cerebral Palsy
    Neurology
    2025
    Experimental Therapy
    Poland
    7
    18
    Cord Tissue
    Allogeneic - Unrelated
    Autism
    Neurology
    2025
    Experimental Therapy
    Poland
    7
    19
    Cord Blood
    Allogeneic - Related
    Thalassemia Major
    Hematology
    2025
    Standard Therapy
    Turkey
    5
    20
    Cord Blood
    Autologous
    Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Poland
    2
    21
    Cord Blood
    Allogeneic - Related
    Thalassemia Major
    Hematology
    2025
    Standard Therapy
    Turkey
    6
    22
    Cord Blood
    Allogeneic - Related
    Cerebral Palsy
    Neurology
    2025
    Experimental Therapy
    Portugal
    1
    23
    Cord Blood
    Autologous
    Autism
    Neurology
    2025
    Experimental Therapy
    Romania
    5
    24
    Cord Blood
    Allogeneic
    Acute lymphoblastic leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    13
    25
    Cord Blood
    Autologous
    Autism
    Neurology
    2025
    Experimental Therapy
    Poland
    5
    26
    Cord Blood
    Autologous
    Autism
    Neurology
    2025
    Experimental Therapy
    Poland
    7
    27
    Bone Marrow Family
    Allogeneic
    Myelofibrosis
    Hematology
    2025
    Standard Therapy
    Poland
    71
    28
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    United Kingdom
    72
    29
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    France
    47
    30
    Bone Marrow Family
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    Ukraine
    43
    31
    Bone Marrow Family
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Italy
    49
    32
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    France
    51
    33
    Bone Marrow Family
    Allogeneic
    Philadelphia - positive Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    61
    34
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    France
    58
    35
    Bone Marrow Family
    Allogeneic
    Myelofibrosis
    Hematology
    2025
    Standard Therapy
    NETHERLANDS
    63
    36
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    65
    37
    Bone Marrow Family
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    France
    63
    38
    Bone Marrow Family
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    Poland
    68
    39
    Bone Marrow Family
    Allogeneic
    Myelofibrosis
    Hematology
    2025
    Standard Therapy
    France
    71
    40
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Russia
    51
    41
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    62
    42
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Czechia
    54
    43
    Bone Marrow
    Allogeneic
    Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Spain
    15
    44
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Norway
    55
    45
    Bone Marrow
    Allogeneic
    Inherited Immune System Disorder
    Hematology
    2025
    Standard Therapy
    France
    3
    46
    Bone Marrow
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    USA
    7
    47
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Ukraine
    36
    48
    Bone Marrow
    Allogeneic
    Inherited Immune System Disorder
    Hematology
    2025
    Standard Therapy
    France
    10
    49
    Bone Marrow
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    USA
    76
    50
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Poland
    39
    51
    Bone Marrow
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    South Africa
    6
    52
    Bone Marrow
    Allogeneic
    Wiskott-Aldrich syndrome
    Hematology
    2025
    Standard Therapy
    Turkey
    6
    53
    Bone Marrow
    Allogeneic
    Combined immnunodeficiency
    Hematology
    2025
    Standard Therapy
    Ukraine
    3
    54
    Bone Marrow
    Allogeneic
    Chronic Granulomatous Disease
    Hematology
    2025
    Standard Therapy
    Poland
    3
    55
    Bone Marrow
    Allogeneic
    Mixed Phenotype Acute Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    13
    56
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Poland
    7
    57
    Bone Marrow
    Allogeneic
    B-cell precursor Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    56
    58
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Poland
    43
    59
    Bone Marrow
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    Poland
    19
    60
    Bone Marrow
    Allogeneic
    Very Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Poland
    12
    61
    Bone Marrow
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    5
    62
    Bone Marrow
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    10
    63
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Poland
    6
    64
    Bone Marrow
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    44
    65
    Bone Marrow
    Allogeneic
    Paroxysmal Nocturnal Hemoglobinuria
    Hematology
    2025
    Standard Therapy
    Poland
    25
    66
    Bone Marrow
    Allogeneic
    Juvenile Myelomonocytic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    4
    67
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    USA
    21
    68
    Bone Marrow
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Italy
    12
    69
    Bone Marrow
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Hungary
    10
    70
    Bone Marrow
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Czechia
    68
    71
    Bone Marrow
    Allogeneic
    Adrenoleukodystrophy
    Hematology
    2025
    Standard Therapy
    Poland
    53
    72
    Bone Marrow
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    4
    73
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    France
    4
    74
    Bone Marrow
    Allogeneic
    Paroxysmal Nocturnal Hemoglobinuria
    Hematology
    2025
    Standard Therapy
    Norway
    18
    75
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    58
    76
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    USA
    34
    77
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Italy
    61
    78
    Apheresis
    Allogeneic
    Myelodysplastic Syndrome/Myeloproliferative neoplasm
    Hematology
    2025
    Standard Therapy
    NETHERLANDS
    62
    79
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Austria
    68
    80
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    70
    81
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    66
    82
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    USA
    77
    83
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Ukraine
    12
    84
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    58
    85
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    USA
    67
    86
    Apheresis
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    4
    87
    Apheresis
    Allogeneic
    Myelofibrosis Myeloid Metaplasia
    Hematology
    2025
    Standard Therapy
    USA
    73
    88
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    56
    89
    Apheresis
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Italy
    50
    90
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    39
    91
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Lithuania
    43
    92
    Apheresis
    Allogeneic
    Chronic Myelomonocytic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    66
    93
    Apheresis
    Allogeneic
    Multiple Myeloma
    Hematology
    2025
    Standard Therapy
    USA
    61
    94
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Austria
    55
    95
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Italy
    69
    96
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Denmark
    67
    97
    Apheresis
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    United Kingdom
    75
    98
    Apheresis
    Allogeneic
    T - cell Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    24
    99
    Apheresis
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    Belgium
    68
    100
    Apheresis
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Ukraine
    42
    Page
    von77
    100 Rangées
    Chargement